Table 2.
Medium potency anticholinergics (Score 2).
| Drug Name | ATC Code | Carnahan 2006 | Rudolph 2008 | Boustani 2008 |
Durán 2013 | Salahudeen 2015 |
Kiesel 2018 | Jun 2019 |
|---|---|---|---|---|---|---|---|---|
| Amantadine | N04BB01 | 1 | 2 | 2 | 1 or 2 | 1 or 2 | 2 | 2 |
| Baclofen | M03BX01 | 0 | 2 | 2 | 2 | 1 | 1 | |
| Carbamazepine | N03AF01 | 2 | 2 | 1 or 2 | 1 or 2 | 2 | 1 | |
| Cloperastine | R05DB21 | 2 | ||||||
| Cimetidine | A02BA01 | 2 | 2 | 1 | 2 | 1 or 2 | 2 | 2 |
| Cyclobenzaprine | M03BX08 | 2 | 2 | 2 | 1 or 2 | 1 or 2 | 2 | |
| Dosulepin | N06AA16 | 2 | 2 | |||||
| Fluphenazine | N05AB02 | 1 | 3 | 3 | 1 or 3 | 1 | ||
| Loxapine | N05AH01 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Maprotiline | N06AA21 | Disc | 3 | 2 | ||||
| Meperidine * | N02AB02 | 2 | 2 | 2 | 2 | 2 | ||
| Methadone | N07BC02 | 2 | 2 | 2 | ||||
| Molindone | N05AE02 | 2 | 2 | 2 | 2 | 2 | ||
| Nefopam | N02BG06 | 2 | 2 | |||||
| Olanzapine | N05AH03 | 1 | 2 | 3 | 1 or 2 | 1, 2 or 3 | 2 | 3 |
| Oxcarbazepine | N03AF02 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Paroxetine | N06AB05 | 1 | 1 | 3 | 1 or 2 | 1, 2 or 3 | 2 | 2 |
| Perphenazine | N05AB03 | 1 | 3 | 3 | Disc | 1, 2 or 3 | 1 | 2 |
| Pimozide | N05AG02 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Prochlorperazine | N05AB04 | 1 | 2 | 1 or 2 | 1 or 2 | |||
| Promazine | N05AA03 | 3 | 2 | 2 | ||||
| Propoxyphene | N02AC04 | 0 | 1 or 2 | 2 | ||||
| Quetiapine | N05AH04 | 0 | 1 | 3 | 1 or 2 | 1, 2 or 3 | 2 | 2 |
| Ranitidine | A02BA02 | 2 | 1 | 1 or 2 | 1 or 2 | 2 | 1 | |
| Tramadol | N02AX02 | 1 | 1 or 2 | 1 or 2 | 2 | 2 | ||
| Triprolidine | R06AX07 | 2 | ||||||
| Zotepine | N05AX11 | 2 | ||||||
| Zuclopenthixol | N05AF05 | 2 |
* Meperidine/ Pethidine. Disc = discrepant for the authors.